Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioQ Pharma is a specialty pharmaceutical company focused on developing and commercializing ready-to-use, unit-dose infusion systems. The company's proprietary technology platform integrates the drug, primary container, and administration set into a single, pre-filled device to enhance safety and clinical efficiency. Its lead commercial product is a ropivacaine infusion system designed for post-operative pain management. BioQ Pharma utilizes a partnership-based commercialization model, collaborating with global leaders to bring its point-of-care infusion solutions to market. The company's systems are designed to be used at the point of care, requiring no programming or complex setup, which reduces the risk of medication errors. This 'one-stop' approach aims to simplify the delivery of infusible drugs in hospital and ambulatory settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioQ.